Sponsor or institution

Clinical trials and research at German Society for Pediatric Oncology and Hematology GPOH gGmbH

• 2Clinical trials
• 1Country

All recruiting trials (2)

• Gudinutuximab Beta Added to Standard Chemo for GD2-Positive Ewing Sarcoma (Early-Phase Trial)

  This early-phase study tests whether adding dinutuximab beta to standard VDC/IE chemotherapy is feasible and safe for patients with GD2-positive high-risk Ewing sarcoma.

  Recruiting at 3 sites Phase 1 German Society for Pediatric Oncology and Hematology GPOH gGmbH · Göttingen, Lower Saxony and 4 other locations · NCT06839703

• Using Nivolumab with chemotherapy for nasopharyngeal carcinoma in children and adults

  This study tests if adding the drug Nivolumab to regular chemotherapy can help children and adults with nasopharyngeal carcinoma respond better to treatment.

  Recruiting at 10 sites Phase 2 German Society for Pediatric Oncology and Hematology GPOH gGmbH · Aachen and 30 other locations · NCT06019130

Quick answers

How many clinical trials run by German Society for Pediatric Oncology and Hematology GPOH gGmbH are recruiting right now?

2, as of November 12, 2026. We update this list each time we refresh our data from ClinicalTrials.gov.

Where are these trials running?

All of them have sites in Germany. Each study page lists its sites and which ones are recruiting.

What phases are they in?

Phase 2: 1, Phase 1: 1. Trials with no phase listed are usually device, behavioural or observational studies.

How do I join one?

Open a study, check the "Is this trial a fit for you?" section, then contact the study team listed on the page. They will ask a few screening questions. Asking is free and does not commit you to anything. Talk it over with your doctor first.

Find the studies that fit you

A list is a starting point. Tell us your situation in your own words and we'll rank the studies that match and explain why. It's free and needs no account.

Describe your situation →